[ad_1]
New system streamlines workflow and improves ease of use
Amsterdam, March 26, 2024–(BUSINESS WIRE)–Stryker (NYSE:SYK), a global leader in medical technology, today announced the release of the Gamma 4 Hip Fracture Nail System in most European markets. The latest Gamma system offers surgeons his Stryker’s next generation intramedullary nail system. The Gamma4 system is designed to treat hip and femoral fractures and streamline the surgeon’s surgical workflow. This system he received his CE certification in Europe in September 2023.
“The Gamma4 system represents the latest chapter in Gamma’s heritage, and after its successful launch in the U.S., we are excited to expand its availability to European customers,” said Stryker’s European Trauma and Extremities Division. said Markus Ochs, vice president and general manager of. “This latest system demonstrates our commitment to working with our customers to understand their needs. With the advanced capabilities of the trusted Gamma System, we believe this system will help our customers rebuild patient lives.” I am.”
Used in more than 25,000 cases in North America and Japan, the Gamma4 System is indicated for the treatment of fractures of the intracapsular, trochanteric, subtrochanteric, and diaphyseal regions of the femur, including osteoporotic and osteopenic bone. I am. The main features are:
-
Nail design redefined. Designed using the SOMA database of over 34,000 3D bone models generated from CT scans1Gamma4 has a chamfered distal tip, a 5 mm shorter proximal body compared to Gamma3, and a length-dependent radius of curvature (RoC) for longer nails.2improves anatomical fit and ease of use.
-
Improved workflow. Precision Pin™ has high pull-out resistance, reducing the likelihood of skiving by 66% compared to standard ∅3.2 K wire.3
-
Integrated instrumentation platform. Gamma4 and T2Alpha nails all now work on the same instrument platform, standardizing surgical procedures.
“The Gamma System has evolved through streamlined processes, standardization, and meticulous attention to detail, all of which improve surgical technique and improve ease of use,” said Dr. Gilbert Taglan, OTCF Education Committee Chair. It is designed to enhance.” “With an unwavering focus on surgeon experience and feedback, our goal was to not only improve ease of use, but prioritize patient health.The new Gamma4 system combines sophisticated instrumentation, advanced The nail design, improved geometry redefines hip fracture treatment and collectively ensures a lasting impact on orthopedic practice for years to come.”
About striker
Stryker is a global leader in medical technology and works with our customers to improve healthcare. The company provides innovative products and services in MedSurg, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. With customers around the world, Stryker impacts more than 150 million patients annually. For more information, please visit www.stryker.com.
Surgeons must always rely on their own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not provide medical advice and recommends that surgeons receive training in the use of specific products before using them in surgery.
The information presented is intended to demonstrate the breadth of products offered by Stryker. Surgeons should always refer to the package insert, product label, and/or instructions for use before using Stryker products. Product availability is subject to individual market regulations and medical practices and therefore may not be available in all markets. If you have any questions about product availability in your area, please contact your sales representative.
Content ID: G4-AD-13, 02-2024
References
-
Internal Report D0000124129, Rev AD
-
Internal report № D0000089997, revised AA
-
Stryker: Internal Test Report D0000099352, Rev AE
View source version on businesswire.com. https://www.businesswire.com/news/home/20240326868923/ja/
contact address
media contact
andrea sampson
President and CEO, Sampson Public Relations Group
asampson@sampsonprgroup.com
562.304.0301
[ad_2]
Source link
